Jennison Associates LLC Purchases 184,896 Shares of LifeStance Health Group, Inc. (NASDAQ:LFST)

Jennison Associates LLC increased its position in LifeStance Health Group, Inc. (NASDAQ:LFST - Free Report) by 9.5% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 2,136,942 shares of the company's stock after acquiring an additional 184,896 shares during the period. Jennison Associates LLC owned about 0.56% of LifeStance Health Group worth $14,959,000 at the end of the most recent reporting period.

A number of other hedge funds also recently bought and sold shares of LFST. CIBC Asset Management Inc bought a new stake in LifeStance Health Group during the second quarter valued at approximately $53,000. Bessemer Group Inc. grew its position in shares of LifeStance Health Group by 43.4% during the 1st quarter. Bessemer Group Inc. now owns 9,143 shares of the company's stock valued at $56,000 after acquiring an additional 2,768 shares during the period. Algert Global LLC purchased a new stake in shares of LifeStance Health Group in the 2nd quarter worth $57,000. Victory Capital Management Inc. raised its holdings in LifeStance Health Group by 27.0% in the 2nd quarter. Victory Capital Management Inc. now owns 14,407 shares of the company's stock worth $71,000 after purchasing an additional 3,063 shares during the period. Finally, Park Edge Advisors LLC purchased a new position in LifeStance Health Group during the third quarter valued at $73,000. Hedge funds and other institutional investors own 85.50% of the company's stock.

LifeStance Health Group Trading Up 1.2 %

LFST traded up $0.09 on Friday, hitting $7.40. The company had a trading volume of 1,515,048 shares, compared to its average volume of 1,940,664. The business's fifty day simple moving average is $7.02 and its 200 day simple moving average is $6.26. The company has a quick ratio of 1.32, a current ratio of 1.32 and a debt-to-equity ratio of 0.19. LifeStance Health Group, Inc. has a 12-month low of $4.64 and a 12-month high of $9.20. The company has a market cap of $2.83 billion, a PE ratio of -28.46 and a beta of 1.24.

LifeStance Health Group (NASDAQ:LFST - Get Free Report) last released its earnings results on Thursday, November 7th. The company reported ($0.02) earnings per share for the quarter, beating the consensus estimate of ($0.07) by $0.05. The firm had revenue of $312.70 million for the quarter, compared to the consensus estimate of $302.25 million. LifeStance Health Group had a negative return on equity of 6.66% and a negative net margin of 7.90%. The company's revenue for the quarter was up 18.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted ($0.17) EPS. Equities research analysts expect that LifeStance Health Group, Inc. will post -0.22 EPS for the current year.

Wall Street Analysts Forecast Growth

Several research analysts recently weighed in on LFST shares. UBS Group dropped their target price on shares of LifeStance Health Group from $9.00 to $7.50 and set a "neutral" rating for the company in a report on Thursday, August 15th. Barclays upped their price objective on LifeStance Health Group from $6.00 to $7.00 and gave the stock an "underweight" rating in a research note on Monday, November 11th. One research analyst has rated the stock with a sell rating, two have issued a hold rating and two have assigned a buy rating to the stock. According to MarketBeat.com, LifeStance Health Group currently has an average rating of "Hold" and a consensus price target of $8.50.

LifeStance Health Group Profile

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.